MetLife Investment Advisors LLC acquired a new stake in shares of Morgan Stanley (NYSE:MS) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 430,721 shares of the financial services provider’s stock, valued at approximately $22,600,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Exane Derivatives increased its position in shares of Morgan Stanley by 303.9% during the fourth quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock valued at $104,000 after purchasing an additional 1,489 shares during the period. First Dallas Securities Inc. bought a new stake in Morgan Stanley in the fourth quarter valued at $121,000. Invictus RG grew its position in Morgan Stanley by 307.5% in the third quarter. Invictus RG now owns 2,335 shares of the financial services provider’s stock valued at $112,000 after acquiring an additional 1,762 shares during the period. Rational Advisors LLC bought a new stake in Morgan Stanley in the third quarter valued at $116,000. Finally, Zions Bancorporation grew its position in Morgan Stanley by 176.1% in the third quarter. Zions Bancorporation now owns 2,463 shares of the financial services provider’s stock valued at $119,000 after acquiring an additional 1,571 shares during the period. Institutional investors and hedge funds own 86.06% of the company’s stock.
In other Morgan Stanley news, Chairman James P. Gorman sold 100,000 shares of the stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $55.34, for a total value of $5,534,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jonathan Pruzan sold 52,204 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $55.35, for a total value of $2,889,491.40. The disclosure for this sale can be found here. Insiders sold 239,254 shares of company stock worth $13,085,019 in the last three months. Insiders own 0.24% of the company’s stock.
Morgan Stanley stock opened at $57.51 on Monday. The company has a debt-to-equity ratio of 2.75, a quick ratio of 0.77 and a current ratio of 0.77. Morgan Stanley has a one year low of $40.06 and a one year high of $59.38. The stock has a market capitalization of $103,049.06, a price-to-earnings ratio of 18.61, a PEG ratio of 0.99 and a beta of 1.50.
Morgan Stanley (NYSE:MS) last issued its quarterly earnings results on Thursday, January 18th. The financial services provider reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.07. Morgan Stanley had a return on equity of 10.07% and a net margin of 14.10%. The business had revenue of $9.50 billion for the quarter, compared to analyst estimates of $9.25 billion. During the same quarter in the prior year, the firm posted $0.81 earnings per share. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. analysts forecast that Morgan Stanley will post 4.53 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “MetLife Investment Advisors LLC Acquires New Stake in Morgan Stanley (MS)” was reported by Week Herald and is the sole property of of Week Herald. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://weekherald.com/2018/03/19/metlife-investment-advisors-llc-acquires-new-stake-in-morgan-stanley-ms.html.
Morgan Stanley Company Profile
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.